Paul Fowler

Following his BSc Hons and PhD in Zoology, Professor Fowler worked on MRI and then ovarian hormones in Obstetrics & Gynaecology, University of Aberdeen. In 2000, he moved to the University of Aberdeen’s Institute of Medical Sciences and subsequently served as its director for 6 years (2015-21). His career focus is elucidating mechanisms regulating and dysregulating reproduction and development from an endocrine focus. He has over 170 peer-reviewed publications and book chapters as well as participating in numerous European Food Standards Agency opinions. Since 2000, his research has focused principally on effects of environmental/lifestyle exposures, such as maternal smoking, obesity, and medication use. This has aimed to understand endocrine disruption of fetal development and health. For the last 15 years the main model used by his group is the normal first and second trimester human fetus. Since 2009 he has led or participated in 3 large EU research programmes studying endocrine disruption. The Fowler group has also been funded by MRC, BBSRC, Wellcome Trust as well as various charities and participates in PARC (Partnership of the Assessment of Risks from Chemicals, 2022-2029). His role in the INITIALISE project is to oversee the Scottish Advanced Fetal Research project (SAFeR) which provided human fetal material to the project.